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The establishment of protective humoral immunity is dependent on the ability of mature B cells to undergo antibody gene
diversification while adjusting to the physiological stressors induced by activation with the antigen. Mature B cells diversify
their antibody genes by class switch recombination (CSR) and somatic hypermutation (SHM), which are both dependent on
efficient induction of activation-induced cytidine deaminase (AID). Here, we identified PDGFA-associated protein 1 (Pdap1) as
an essential regulator of cellular homeostasis in mature B cells. Pdap1 deficiency leads to sustained expression of the integrated
stress response (ISR) effector activating transcription factor 4 (Atf4) and induction of the ISR transcriptional program,
increased cell death, and defective AID expression. As a consequence, loss of Pdap1 reduces germinal center B cell formation
and impairs CSR and SHM. Thus, Pdap1 protects mature B cells against chronic ISR activation and ensures efficient antibody
diversification by promoting their survival and optimal function.
Introduction
The diversity of our Ig gene repertoire is the result of antibody
diversification reactions occurring at different stages of B lym-
phocyte development (Dudley et al., 2005; Methot and Di Noia,
2017). Developing B cells in the bonemarrow randomly assemble
different gene segments (known as variable, V; diversity, D; and
joining, J, genes) at the Ig heavy (Igh) and light (Igl) chain loci via
V(D)J recombination (Roth, 2014; Dudley et al., 2005). This
process generates unique antibody gene receptors with the po-
tential to collectively recognize a formidable number of anti-
gens. Mature B cells further diversify their Ig genes in the
periphery via somatic hypermutation (SHM) and class switch
recombination (CSR; Pavri and Nussenzweig, 2011; Methot and
Di Noia, 2017). SHM introduces point mutations into the varia-
ble V(D)J region of the Ig genes to generate higher-affinity
variants. CSR recombines the Igh constant (C) regions to re-
place the C portion of the IgM heavy chain with one of the al-
ternative isotypes (IgG, IgA, and IgE), thus diversifying the Ig
effector function. SHM and CSR are crucial to mount protective
humoral responses, as evidenced by primary human immuno-
deficiency syndromes that are caused by defects in these re-
actions (Durandy et al., 2013).
SHM and CSR are both dependent on the B cell–specific en-
zyme activation-induced cytidine deaminase (AID; Revy et al.,
2000; Muramatsu et al., 2000). AID deaminates cytosine resi-
dues to uracil in single-stranded DNA stretches at the variable
regions of both Igh and Igl loci during SHM, and within special
recombining elements (switch [S] regions) of the Igh during CSR
(Bransteitter et al., 2003; Chaudhuri et al., 2003; Petersen-
Mahrt et al., 2002; Pham et al., 2003; Sohail et al., 2003;
Ramiro et al., 2003; Dickerson et al., 2003; Matthews et al., 2014;
Methot and Di Noia, 2017). The resulting U:G mismatches are
differentially processed to generate either mutations in the
variable regions or DNA breaks in the S regions (Peled et al.,
2008; Methot and Di Noia, 2017; Matthews et al., 2014). AID
expression is induced when resting mature (naı¨ve) B cells are
activated by the antigen and T cell interactions (Zhou et al.,
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2003; Sayegh et al., 2003; Gonda et al., 2003; Cunningham et al.,
2004; Dedeoglu et al., 2004; Muramatsu et al., 1999). Antigen
stimulation reprograms naı¨ve B cells to exit the quiescent state,
expand their cellular biomass, and undergo a proliferative burst
within transient and anatomically distinct structures in sec-
ondary lymphoid organs called germinal centers (GCs; Cyster
and Allen, 2019; Victora and Nussenzweig, 2012). AID expres-
sion peaks in GC B cells (Cattoretti et al., 2006; Crouch et al.,
2007; Roco et al., 2019). The GC reaction represents the end stage
of B cell development, as GC B cells differentiate into memory
B cells or long-lived plasma cells that secrete high-affinity
antibodies.
The integrated stress response (ISR) is a homeostatic pro-
gram activated by a variety of physiological and pathological
stresses to promote cellular recovery (Ron and Walter, 2007;
Pakos-Zebrucka et al., 2016). These stresses include both cell-
intrinsic and -extrinsic stimuli, such as ER stress, mitochondrial
dysfunction, hypoxia, and amino acid deprivation (Quirós et al.,
2017; Harding et al., 1999, 2003; Dever et al., 1992; Rzymski et al.,
2010; Ye et al., 2010). All forms of stress converge into the
phosphorylation of the α subunit of the eukaryotic translation
initiation factor 2 (eIF2α) on serine 51 (Donnelly et al., 2013).
This event causes a reduction in global protein synthesis while
allowing the preferential translation of few selected genes in-
cluding the ISR effector activating transcription factor 4 (Atf4;
Hinnebusch, 2000; Harding et al., 2000; Scheuner et al., 2001;
Lu et al., 2004). Atf4 induces the transcriptional up-regulation of
stress-responsive genes and rewires cell metabolism toward the
recovery of cellular homeostasis (Harding et al., 2003). The in-
hibition of general protein translation in the early stage of the
ISR is followed by a later phase of translational recovery, which
restores protein synthesis once the stress is resolved to support
cell survival (Brostrom and Brostrom, 1998; Novoa et al., 2003;
Kojima et al., 2003; Marciniak et al., 2004; Brostrom et al., 1989;
Ma and Hendershot, 2003).
Although the ISR is an adaptive program meant to restore
cellular homeostasis and promote cell survival, under conditions
of severe or prolonged stress, it induces cell death by activating
proapoptotic pathways (Zou et al., 2008; Puthalakath et al.,
2007; Teske et al., 2013; Wang et al., 2009; Ohoka et al., 2005;
Gupta et al., 2012; Hiramatsu et al., 2014; Marciniak et al., 2004).
Furthermore, the sustained protein synthesis during chronic
stress causes proteotoxicity and leads to cell death (Han et al.,
2013; Krokowski et al., 2013). Here, we identified Pdap1 as an
essential regulator of mature B cell physiology that functions by
countering chronic activation of the ISR. Pdap1 ablation in ma-
ture B cells causes sustained expression of Atf4, long-term in-
duction of the ISR transcriptional program, and cell death.
Furthermore, Pdap1 is essential for efficient induction of AID
expression and physiological levels of CSR and SHM.
Results
Pdap1 is required for efficient CSR
To identify novel modulators of mature B cell physiology, we
performed loss-of-CSR screens via somatic gene targeting by
CRISPR-Cas9 in the B cell lymphoma line CH12. CH12 cells share
several properties of resting B cells and have been used to study
key aspects of late B cell differentiation, including B cell acti-
vation, antibody diversification by CSR, and immunoglobulin
secretion (Arnold et al., 1983; Stockdale et al., 1987; Wiest et al.,
1990; Corley et al., 1985; Bishop and Haughton, 1986; Nakamura
et al., 1996; Ovnic and Corley, 1987; Fagone et al., 2007; Gass
et al., 2002; Dufort et al., 2014; LoCascio et al., 1984a, 1984b).
Upon cytokine stimulation, CH12 cells express AID and undergo
CSR to IgA with high efficiency (Nakamura et al., 1996). CRISPR-
Cas9–mediated deletion of factors required for CSR reduces the
efficiency of isotype switching in this cell line (Delgado-Benito
et al., 2018). Among all tested candidates, targeting of Pdap1
resulted in a considerable reduction of CSR (Fig. 1, A and B). To
confirm the results of the loss-of-CSR screen, we generated
Pdap1-deficient CH12 clonal derivative cell lines, which included
both indel knockout (Pdap1−/−) and in-frame deletion mutant
(Pdap1mut) clones (Fig. 1, C and D). In agreement with the CSR
defect observed in bulk CH12 cultures, CSR was impaired in
Pdap1-deficient clonal derivatives (Fig. 1 E). We concluded that
Pdap1 supports efficient CSR in CH12 cells.
Pdap1 is a 28-kD phosphoprotein highly conserved in verte-
brates. It was originally identified as a casein kinase II substrate
and a weak interactor of platelet-derived growth factor A
(PDGF-A; Shen et al., 1996; Fischer and Schubert, 1996). More
recently, Pdap1 was described as an RNA-binding protein in
several RNA–protein interactome studies (Castello et al., 2012,
2016; Trendel et al., 2019; Baltz et al., 2012; Iadevaia et al., 2020).
However, the precise cellular functions of Pdap1 and its in-
volvement in adaptive immunity are unknown.
To verify Pdap1 involvement in CSR in vivo and elucidate the
underlying mechanism, we generated a mouse model bearing a
conditional Pdap1F allele and bred it to Cd19Cre/+ mice to specifi-
cally ablate Pdap1 expression at the early stages of B cell dif-
ferentiation (Rickert et al., 1997; Fig. S1, A and B). B cell
development was largely unaffected in Pdap1F/FCd19Cre/+ mice
(Fig. S1, C and D). Although incomplete Cd19Cre-mediated re-
combination of Pdap1F in B cell progenitors could still mask a
potential phenotype, these results suggest that Pdap1 is dis-
pensable for V(D)J recombination and early B cell differentia-
tion. However, we observed a pronounced reduction in the
number of splenic resting mature B cells (Fig. S1 E). To confirm
the intrinsic CSR defect caused by Pdap1 deficiency, we isolated
resting splenocytes from Pdap1F/FCd19Cre/+ mice and monitored
their capability to undergo CSR upon in vitro stimulation. We
assessed CSR under conditions that induce switching to IgG1,
IgG3, IgG2b, and IgA and found that Pdap1-deficient B cells
displayed reduced levels of CSR for all tested isotypes (Fig. 2,
A–D). Western blot (WB) analysis confirmed the near-complete
abrogation of Pdap1 expression in these cells (Fig. 2 E). Alto-
gether, these data indicate that Pdap1 is required for efficient
CSR in primary B cells irrespective of the stimulation condition.
Pdap1 supports physiological levels of AID expression
CSR is dependent on cell proliferation (Hasbold et al., 1998, 1999;
Hodgkin et al., 1996; Deenick et al., 1999). To determine if the
reduced CSR efficiency of Pdap1-deficient B cells is caused by
an underlying defect in cell proliferation, we monitored the
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Figure 1. Loss of Pdap1 in CH12 cells impairs CSR. (A) Scheme of murine Pdap1 genomic locus and location of gRNAs used for gene targeting (scheme
adapted from Ensembl Pdap1-201 ENSMUST00000031627.8). (B) Top left: Representative flow cytometry plots measuring CSR to IgA in activated Cas9/
gPdap1-nucleofected CH12 cells. Numbers in the plots refer to the percentage of switched cells (= IgA+ cells). Top right: Summary graph for three independent
experiments using gPdap1-1/3 (individually or in pooled format) or Nickases-a/c (individually). Controls for gRNA-nucleofected CH12 were cells electroporated
with either empty vector or gRNAs against random sequences not present in the mouse genome (gCtrl). A previously described gRNA against the CSR factor
53BP1 (Delgado-Benito et al., 2018) was used as a positive control for loss-of-CSR function. Bottom: WB analysis of whole-cell extracts from CH12 cultures
nucleofected with Nickase-a to -c. Triangles indicate twofold dilution. Asterisk denotes aspecific bands used for internal normalization of protein levels. N,
Nickase. (C) Graph summarizing CSR efficiency of activated CH12 clonal cell lines derived by nucleofection of CH12 cultures with Nickase-a/c and single-cell
sorting. Each symbol in the graphs indicates a single-cell clonal derivative. (D) Left: Genomic scars of the targeted alleles in the selected Pdap1-deficient CH12
clonal derivatives. fs, frameshift; PTC, premature termination codon; Δ, bp deletion; het, heterozygous configuration (different indels causing fs and PTC
at the two Pdap1 alleles); homo, homozygous configuration. Right: Representative WB analysis of WT and Pdap1-deficient CH12 cell lines. R1 and R2 are
WT clonal derivatives generated by targeting CH12 with random sequences not present in the mouse genome. mut, mutated. Asterisk denotes aspecific
bands. Numbers underneath the blot indicate relative quantification of Pdap1 signal. (E) Left: Representative flow cytometry plots measuring CSR to IgA
in activated CH12 cell lines of the indicated genotypes. WT controls included both the parental CH12 cell line (WT) and the random clonal derivatives R1
and R2. Right: Summary graph for four independent experiments. Significance in B, C, and E was calculated with the Mann–Whitney U test, and error
bars represent SD. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.
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Figure 2. Pdap1 promotes CSR in primary
B cells. (A–D) Left: Representative flow cytom-
etry plots measuring CSR to IgG1 (A), IgG3 (B),
IgG2b (C), and IgA (D) in splenocytes activated
with LPS and IL-4 (A), LPS (B), LPS, BAFF, and
TGFβ (C), or LPS, BAFF, TGFβ, and IL-5 (D).
Numbers in the plots refer to the percentage of
switched cells (= IgG1+/IgG3+/IgG2b+/IgGA+ cells).
Right: Summary graph for at least six mice per
time point per genotype. (E) WB analysis of
whole-cell extracts from B cells of the indicated
genotypes 96 h after stimulation with LPS and IL-
4 (left) or LPS, BAFF, and TGFβ (right). 1 and
2 indicate two different Pdap1F/FCd19Cre/+ mice.
Triangles indicate threefold dilution. Asterisk de-
notes aspecific bands. Numbers underneath the
blots indicate relative quantification of Pdap1
signal. Significance in A–D was calculated with
the Mann–Whitney U test, and error bars repre-
sent SD. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001;
****, P ≤ 0.0001. See also Figs. S1 and S2.
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proliferation capabilities of splenocyte cultures by cell tracking
dye dilution. TheCellTraceViolet dilution profiles ofPdap1F/FCd19Cre/+
B cells were indistinguishable from the control counterparts
under all stimulation conditions (Fig. S2, A–D). Furthermore,
class switching was reduced in Pdap1-deficient B cells inde-
pendently of the number of cell divisions (Fig. S2 E). We con-
cluded that Pdap1 is dispensable for B cell proliferation, and that
the CSR defect of Pdap1F/FCd19Cre/+ B cells is not due to reduced
proliferation capabilities.
The efficiency of CSR is directly linked to the levels of AID
expression (Dorsett et al., 2008; Takizawa et al., 2008; Teng
et al., 2008). Furthermore, AID targeting is dependent on non-
coding transcription across the S regions (germline transcrip-
tion; GLT), which exposes single-stranded DNA stretches that
are the substrate of AID-mediated deamination (Chaudhuri
et al., 2003; Dickerson et al., 2003; Ramiro et al., 2003).
Therefore, we monitored Aicda mRNA and GLT levels in acti-
vated B cells by quantitative RT-PCR (qPCR) analysis. We found
that Aicda transcript levels were consistently reduced in
Pdap1F/FCd19Cre/+ B cells compared with controls across all stim-
ulation conditions (Fig. 3 A). Transcription of donor Sμ region
was not affected by Pdap1 deletion (Fig. 3 B), whereas acceptor S
region transcription exhibited a varied phenotype, with reduced
levels of GLTγ1 and GLTα, and minimally affected or unaltered
expression for GLTγ3 and GLTγ2b, respectively (Fig. 3 C).
Analogously, analysis of Aicda and germline transcripts in
Pdap1-deficient CH12 cell lines showed reduced Aicda mRNA
levels but unaffected Sμ and Sα region transcription (Fig. S3,
A–C). In agreement with the reduction of Aicda mRNA, Pdap1-
deficient B cells expressed lower levels of AID protein upon
activation compared with control cells (Fig. 3 D).
AID-mediated deamination in the donor Sμ and recombining
acceptor S region leads to the formation of DNA double-strand
breaks (DSBs), which are ultimately repaired by end joining to
ensure productive CSR events (Matthews et al., 2014; Boboila
et al., 2012). The reduced AID expression and isotype-specific
GLT phenotypes of Pdap1-deficient B cells converge into a pre-
DSB defect, since DSB formation at S regions relies on both AID
levels and efficient targeting. These results, however, did not
exclude the possibility that Pdap1 might play an additional role
during CSR downstream break formation, for example in repair
of S region DSBs. To test this possibility, we overexpressed AID
in Pdap1-deficient B cells and monitored the levels of CSR (Fig. 3
E). To this end, we transduced control and Pdap1F/FCd19Cre/+
splenocytes with a construct expressing AID fused to the
hormone-binding domain of the modified estrogen receptor
(AID-ER). Provision of 4-hydroxytamoxifen (4-HT) induces the
translocation of the cytoplasm-accumulated AID-ER fusion
protein into the nucleus and initiates CSR. We found that 4-HT
addition rescued the CSR defect of Pdap1F/FCd19Cre/+ cells to levels
equivalent to AID-ER–reconstituted Aicda−/− splenocytes in cul-
tures stimulated to undergo class switching to IgG2b (Fig. 3 E),
which exhibited unaffected GLTγ2b (Fig. 3 C). In contrast, the
rescue of CSR was not significant in cells activated to switch to
IgG1, with severely reduced GLTγ1 in the absence of Pdap1
(Fig. 3, C and E), and therefore impaired in AID targeting even
under conditions of increased AID levels. Altogether, these data
indicate that the CSR defect of Pdap1-deficient B cells is caused
by impaired formation of AID-induced DSBs, which is caused
primarily by reduced AID expression, with the additional con-
tribution of impaired GLT in an isotype-specific manner.
Pdap1 has been recently identified in RNA-protein capture
experiments as an RNA binding protein (Castello et al., 2012,
2016; Trendel et al., 2019; Baltz et al., 2012; Iadevaia et al., 2020).
Therefore, we considered the possibility that Pdap1 might con-
tribute to the posttranscriptional regulation of AID expression.
Because Pdap1 is localized primarily in the cytoplasm (Fig. S4),
we first tested whether Pdap1 controls the degradation of Aicda
mRNA. To do so, we treated Cd19Cre/+ and Pdap1F/FCd19Cre/+
splenocyte cultures with Actinomycin D to inhibit the de novo
transcription of AID and measured Aicda mRNA decay by qPCR.
We found that depletion of Pdap1 did not affect the kinetics of
Aicda mRNA degradation (Fig. 4, A and B). This result also in-
directly shows that Pdap1 deficiency does not alter decapping or
deadenylation of Aicda transcripts since a defect in any of these
processes would result in accelerated decay. We concluded that
Pdap1 is dispensable for Aicda transcript stability. Next, we
monitored Aicda transcript splicing. Several splice variants
for AID have been identified, with the full-length transcript
being the only splice isoform encoding a functional AID protein
(van Maldegem et al., 2009, 2010; Sala et al., 2015). To assess
whether Pdap1 modulates Aicda splicing, we performed RNA
next-generation sequencing (RNA-seq) of activated B cells in-
duced to undergo CSR to either IgG1 or IgG2b and analyzed the
pattern of Aicda exon usage. We found no difference in the profile
of Aicda exon usage between Cd19Cre/+ and Pdap1F/FCd19Cre/+ B cells
(Fig. 4 C). Furthermore, primary Aicda transcript levels in
Pdap1F/FCd19Cre/+ splenocytes were reduced compared with
Cd19Cre/+ cells to an extent similar to that observed for the full-
length spliced product (Figs. 4 D and 3 A). We concluded that
ablation of Pdap1 does not affect AicdamRNA splicing. Altogether,
these findings indicate that Pdap1 supports physiological levels of
AID expression, and that the CSR defect of Pdap1-deficient B cells
is caused, at least in part, by impaired induction of AID expression
following activation rather than a defect in Aicda posttranscrip-
tional regulation.
Pdap1 deficiency in B cells induces the Atf4 stress response
transcriptional program
To define the mechanism responsible for the defective induction
of AID expression in Pdap1-deficient cells, we compared the
transcriptome profiles of Cd19Cre/+ and Pdap1F/FCd19Cre/+ spleno-
cytes stimulated with either LPS and IL-4 or LPS, B cell–
activating factor (BAFF), and TGFβ (Table S1). The use of two
stimulation conditions allowed us to zoom in common differ-
entially regulated pathways and added a temporal dimension to
the experiment, since LPS-BAFF-TGFβ–stimulated splenocytes
proliferate faster than LPS-IL-4–activated ones (Fig. S2 F). To
identify differentially expressed genes, we set the significance
level of false discovery rate (FDR) to <0.05 (Fig. 5 A). The
number of differentially regulated genes was higher in LPS-IL-
4–stimulated cultures than in LPS-BAFF-TGFβ–activated cells
(1,227 versus 173). Furthermore, the number of genes up-
regulated in Pdap1F/FCd19Cre/+ was considerably higher than the
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Figure 3. Pdap1 supports physiological levels of AID expression. (A–C) qPCR analysis for AicdamRNA (A), Igμ (B), and Igγ1/Igγ3/Igγ2b/Igα (C) GLT levels in
B cells activated to undergo CSR to the corresponding isotypes. The schematic representations on the left in B and C indicate the location of primers used to
analyze the germline transcripts. Graphs summarize four to eight mice per genotype per stimulation condition. One control mouse (Cd19Cre/+ or Pdap1F/F) within
each experiment was assigned an arbitrary value of 1. (D) RepresentativeWB analysis of splenocytes of the indicated genotypes 48 h after stimulation with LPS
and IL-4. 1 and 2 indicate two different mice per genotype. Triangles indicate threefold dilution. Arrowhead and asterisk denote AID and aspecific band,
respectively. Numbers underneath the blot indicate relative quantification of AID signal. (E) Summary graphs showing CSR to IgG2b (top) and IgG1 (bottom)
following transduction of splenocytes of the indicated genotypes with either empty vector (EV) or an AID-ER–expressing retroviral construct. Graphs
summarize three to eight mice per genotype analyzed in three (IgG2b) or four (IgG1) independent experiments. Different colors are used to group
samples based on genotype (red for Aicda−/−, black for controls, and green for Pdap1F/FCd19Cre/+). Empty and filled column bars indicate samples infected
with EV and AID-ER constructs, respectively. Significance in A, C, and E was calculated with the Mann–Whitney U test. Error bars represent SD. ns, not
significant; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. See also Fig. S3.
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down-regulated ones in LPS-BAFF-TGFβ–stimulated cultures
(124 up- versus 49 down-regulated) but was evenly distributed
between the two categories in the LPS-IL-4 stimulation condi-
tion (561 up- versus 666 down-regulated).
Pathway enrichment analysis of the down-regulated genes in
Pdap1F/FCd19Cre/+ B cells in the LPS-IL-4 dataset identified the
protein translation–related categories “ribosome,” “ribosome
biogenesis in eukaryotes,” and “RNA transport” as the most
significant categories (Fig. 5 B). Furthermore, analysis of indi-
vidual genes showed that the most significantly down-regulated
ones under both stimulations were factors essential for CSR and/
or genes highly expressed or induced in activated B cells (e.g.,
Aicda, Batf, Ccl22, Ighg3, and Tmem176b; Fig. 5 C and Table S1). In
contrast, the top up-regulated categories in both datasets were
related to metabolic pathways of amino acid and aminoacyl-
tRNA biosynthesis (Fig. 5 B). Among the most significantly up-
regulated genes, we found key enzymes for the biosynthesis of
asparagine (Asns), cysteine (Cth), and serine (Psat1, Psph), glu-
tathione metabolism (Chac1), amino acid transporters (Slc1a4,
Slc6a9), and several other metabolic and cytoprotective genes
(Fig. 5 C, Fig. S5 A, and Table S1).
These data indicate that, in addition to the inhibition of key
factors of the CSR program, Pdap1 deficiency in activated B cells
is accompanied by transcriptional changes that reflect initial
repression of global protein synthesis, up-regulation of cellular
stress response genes, and metabolic rewiring to aid transla-
tional recovery. These changes represent key aspects of the
transcriptional program of the ISR (Ron and Walter, 2007;
Pakos-Zebrucka et al., 2016). To confirm the activation of the ISR
in Pdap1-deficient B cells, we monitored the kinetics of eIF2α
Figure 4. Pdap1 is dispensable for Aicda
mRNA stability and splicing. (A and B) Left:
qPCR analysis for AicdamRNA from B cells of the
indicated genotypes stimulated with LPS and IL-
4 (A) or LPS, BAFF, and TGFβ (B) for 48 h to
induce CSR to IgG1 or IgG2b, respectively, and
treated with Actinomycin D for the indicated
time. Graph summarizes the mean of two inde-
pendent qPCR measurements per mouse for
two mice per genotype. Right: Linear regression
analysis of the same data, shown as ln[RNA]
versus time of Actinomycin D treatment.
(C) Analysis of exon usage for Aicda (left) and
Pdap1 (right) genes. Pdap1 splicing data are pro-
vided as a positive control for the spicing
analysis. A schematic representation of each
gene is provided above. (D) Left: Schematic
representation of Aicda gene with location of
primers used to analyze Aicda primary and
spliced transcripts. Right: qPCR analysis of Aicda
primary transcripts in B cells 48 h after activa-
tion with LPS. Graphs summarize at least four
mice per genotype. Results of qPCR analysis of
Aicda spliced transcripts are shown in Fig. 3 A.
One Cd19Cre/+ mouse within each experiment
was assigned an arbitrary value of 1. Significance
in D was calculated with the Mann–Whitney U
test, and error bars represent SD. *, P ≤ 0.05.
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Figure 5. Pdap1-deficient B cells activate the Atf4 stress response transcriptional program. (A) Scatterplots of gene expression in Pdap1F/FCd19Cre/+
versus control (Cd19Cre/+) mature B cells stimulated with LPS and IL-4 (top) or LPS, BAFF, and TGFβ (bottom). Genes with an adjusted P value (FDR) < 0.05 that
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phosphorylation and Atf4 expression in resting and in vitro–
activated splenocytes. The eIF2α-Atf4 pathway is normally
suppressed in splenic B cells and is induced only at later time
points after activation, when splenocyte cultures exhibit a
general fitness decline (Fig. 5 D and Fig. S5 B, control cells; Zhu
et al., 2019). In contrast to control cells, resting B cells from
Pdap1F/FCd19Cre/+ spleens displayed a marked phosphorylation of
eIF2α and detectable levels of Atf4 protein, thus indicating a
baseline activation of the ISR (Fig. 5 D and Fig. S5 B). The ER
stress-activated eIF2α kinase PKR-like ER kinase (Perk) also
showed autophosphorylation-dependent activation in resting
splenocytes (Fig. 5 D and Fig. S5 B). eIF2α phosphorylation was
suppressed following activation and was noticeable only in late-
stage cultures when eIF2α levels increased considerably in both
control and Pdap1-deficient cells (Fig. 5 D and Fig. S5 B). In
agreement with a previous report (Zhu et al., 2019), Atf4 was
markedly expressed only at late time points after activation in
control splenocytes (Fig. 5 D). In contrast, Atf4 protein levels in
Pdap1F/FCd19Cre/+ cells increased considerably during the first
24 h after activation from the baseline expression observed in
resting B cells (Fig. 5 D). Finally, up-regulation of Atf4 expres-
sion in the absence of Pdap1 occurred not only at the translation
level but also via transcriptional induction (Fig. 5 C and Fig. S5 A).
We concluded that Pdap1 deficiency results in up-regulation of
the ISR core component Atf4. Altogether, these data indicate
that Pdap1 ablation in mature B cells induces Atf4-dependent
expression of stress response genes and down-regulation of the
CSR program.
Pdap1 supports survival of mature B cells
The ISR is an adaptive pathway meant to restore cellular ho-
meostasis following cell intrinsic and extrinsic stresses (Harding
et al., 1999, 2000, 2003; Brostrom et al., 1996; Dever et al., 1992;
Ron and Walter, 2007; Pakos-Zebrucka et al., 2016). However,
when the stress is severe in either intensity or duration and
overwhelms the response adaptive capacity, the ISR activates
the apoptotic cell death program (Pakos-Zebrucka et al., 2016).
Furthermore, down-regulation studies have implicated Pdap1 in
cell survival and apoptosis resistance of cancer cell lines
(Sharma et al., 2016; Weston et al., 2018). Therefore, we tested
whether activation of the stress response in the absence of
Pdap1 would induce apoptosis in B cells. To do so, we moni-
tored caspase activation in splenocytes by CaspGLOW stain-
ing. Caspase activity increased after stimulation and was higher
in Pdap1-deficient cells compared with controls at 24 and 48 h
after activation (Fig. 6 A). Accordingly, despite the unaffected
proliferation capability (Fig. S2), the number of live cells in
Pdap1F/FCd19Cre/+ splenocyte cultures was reduced 48 and 72 h
after activation (Fig. 6 B). Finally, no differences were detected in
mitochondrial mass or respiration capacity compared with
controls (Fig. 6 C and Fig. S5 C), thus indicating that activation of
the ISR is not caused by mitochondrial disfunction. However,
Pdap1F/FCd19Cre/+ cultures displayed an increased proportion of
cells with low mitochondrial membrane potential at early time
points after activation (24 and 48 h; Fig. 6 D). Hence, a fraction of
Pdap1-deficient B cells may undergomitochondrial depolarization,
an event usually associated with apoptosis induction (Gottlieb
et al., 2003).
Next, we tested whether Pdap1 deletion would affect the
survival of activated B cells in vivo. To this end, we measured
the percentage of GC B cells in Peyer’s patches of Cd19Cre/+ and
Pdap1F/FCd19Cre/+ mice. Peyer’s patches are specialized sec-
ondary lymphoid tissues that line the wall of the small in-
testine. Because of their chronic exposure to an enormous
variety of food- and microbiome-derived antigens, Peyer’s
patches display continual GC activity and are key to the in-
duction of mucosal IgA antibody responses (Reboldi and
Cyster, 2016). We found that the percentage of GC B cells
was reduced in Peyer’s patches of Pdap1F/FCd19Cre/+ mice com-
pared with the control group (Fig. 6 E). In agreement with the
CSR defect exhibited by Pdap1F/FCd19Cre/+ splenic B cells following
activation in vitro (Fig. 2), the percentage of switched IgA GC
B cells was considerably decreased in Pdap1F/FCd19Cre/+ mice
(Fig. 6 E). Altogether, these data suggest that Pdap1 is required to
support survival of activated B cells.
Pdap1 is dispensable for plasma cell differentiation
Plasma cell differentiation represents the terminal phase of
B cell development and is regulated by a transcriptional pro-
gram that represses B cell identity while promoting the ex-
pression of plasma cell signature genes (Nutt et al., 2015; Shi
et al., 2015; Minnich et al., 2016). This process is accompanied
by massive expansion of the ER and the up-regulation of
molecular chaperone and folding enzyme expression. The
expansion of the secretory network is essential to accommo-
date the demands of increased immunoglobulin synthesis and
secretion and is dependent on the activation of the unfolded
protein response (UPR; Zhang et al., 2005; Gass et al., 2002,
2008; Iwakoshi et al., 2003; van Anken et al., 2003; Shaffer
et al., 2004; Taubenheim et al., 2012; Todd et al., 2009). The
UPR is a ubiquitous signaling network that senses and re-
sponds to the accumulation of misfolded proteins in the ER
are up- or down-regulated in Pdap1F/FCd19Cre/+ cells are highlighted in red or purple, respectively. Data summarizes results from three mice per genotype per
stimulation condition and is presented as log2(RPM) (reads per gene per million mapped sequence reads) values. (B) Pathway enrichment analysis (KEGG
pathways) of the differentially regulated genes (FDR < 0.05) from A. The number of differentially regulated genes in each category is indicated. (C) Volcano
plots displaying differentially expressed genes between control and Pdap1-deficient splenocytes activated with LPS and IL-4 (right) or LPS, BAFF, and TGFβ
(left). The red and purple dots represent transcripts up- and down-regulated in Pdap1F/FCd19Cre/+ cells, respectively, with FDR < 0.05 and expression fold
change > 2 (up-regulated) or 1.7 (down-regulated) in both stimulation conditions. The names of the down-regulated and the 30 most significantly up-regulated
genes within each stimulation condition are indicated in each graph. The fold change threshold for down-regulated genes was set to 1.7 to include genes
yielding a biologically relevant effect even with less pronounced variations in expression levels (e.g., Aicda, haploinsufficient gene). (D) Representative WB
analysis of splenocytes of the indicated genotypes before (resting B cells) and after 24–96-h activation with LPS and IL-4. Data are representative of two mice
per genotype, and quantification values of WB signals are indicated underneath the corresponding blots. See also Fig. S5 and Table S1.
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(Ron and Walter, 2007; Walter and Ron, 2011; Schro¨der and
Kaufman, 2005). This response is mediated by three ER-
resident proteins which, in addition to Perk, comprise the
inositol-requiring protein kinase/endoribonuclease-1 (Ire1)
and Atf6 (Tirasophon et al., 1998; Wang et al., 1998; Haze et al.,
1999, 2001). The UPR ultimately reestablishes protein ho-
meostasis by integrating Perk-eIF2α–dependent attenuation
of global protein synthesis with Ire1- and Atf6-mediated
transcription of factors and enzymes that increase the pro-
tein folding and degradation capabilities of the ER.
The Ire1 and Atf6 branches of the UPR are activated
during normal differentiation of naı¨ve B cells into plasma
cells, and the Ire1 arm is essential for the expansion of their
secretory network (Zhang et al., 2005; Gass et al., 2002,
2008; Iwakoshi et al., 2003; van Anken et al., 2003; Aragon
et al., 2012). In contrast, the Perk arm of the UPR is dis-
pensable for plasma cell development (Zhang et al., 2005;
Gass et al., 2008). Furthermore, this pathway is suppressed
during differentiation of naı¨ve B cells into plasma cells (Ma
et al., 2010; Gass et al., 2008; Zhang et al., 2005), and un-
restricted Perk-eIF2α-Atf4 signaling in activated B cells
blocks the formation of plasma cells (Zhu et al., 2019). Given
the up-regulated expression of Atf4 in Pdap1-deficient
B cells, we considered the possibility that plasma cell de-
velopment might be impaired in the absence of Pdap1. To this
end, we analyzed the plasma cell compartment of Pdap1F/FCd19Cre/+
mice. We found that the percentage and number of plasma cells
(CD138+TACI+) in bone marrow and spleen of unimmunized
mice was similar between control and Pdap1F/FCd19Cre/+ mice
(Fig. 7 A).
Figure 6. Pdap1 supports survival of mature
B cells. (A) Top: Representative flow cytometry
plots measuring percentage of active caspase+
cells in resting and activated (LPS-IL-4, or LPS-
BAFF-TGFβ, 24–72 h) splenocytes of the indi-
cated genotypes. Bottom: Summary graph for
four mice per genotype analyzed in two inde-
pendent experiments. (B) Live-cell count of
splenocytes of the indicated genotypes activated
with LPS and IL-4. Resting B cells were counted
and seeded at the same density on day 0. Data
summarize three independent experiments for a
total of six mice per genotype and are normal-
ized within each experiment to the average of
live-cell count for control cultures at 48 h, which
was set to 1. (C) Mitochondrial mass of resting
and LPS + IL-4–activated splenocytes (24–72 h)
as determined byMitoTracker green staining and
expressed as mean fluorescence intensity (MFI)
values. Graphs summarize results from a total of
3–11 mice per genotype analyzed in four inde-
pendent experiments. (D) Left: Representative
flow cytometry plots measuring mitochondrial
membrane potential (MMP) and mass by Mito-
Tracker deep red and green staining, respec-
tively, in splenocyte cultures of the indicated
genotype 24, 48, and 72 h after activation with
LPS and IL-4. Right: Summary graph for seven
mice per genotype. (E) Left: Representative flow
cytometry plots measuring percentage of GC
B cells and IgA+ GC cells in Peyer’s patches (PP)
of unimmunized mice. Right: Summary graphs
for at least five mice per genotype. Signifi-
cance in A–E was calculated with the Mann–
Whitney U test, and error bars represent SD.
*, P ≤ 0.05; **, P ≤ 0.01.
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Figure 7. Pdap1 is dispensable for plasma cell differentiation. (A) Top: Representative flow cytometry plots showing percentage of plasma cells
(CD138+TACI+) in bone marrow (BM) and spleen (SPL) of unimmunized mice of the indicated genotypes and age. Bottom: Summary graphs showing percentage
and number of plasma cells for three mice per genotype and age group. N, number. (B) Left: Representative flow cytometry plots measuring percentage of
plasmablasts (B220intCD138+) in splenocyte cultures of the indicated genotypes 96 h after activation with LPS and IL-4, or LPS, BAFF, and TGFβ. Right:
Summary graph for six mice per genotype. (C) Top: Schematic representation of Xbp1mRNA RT-PCR and digestion products. Bottom: Electrophoretic analysis
of Xbp1 splicing in splenocytes cultures of the indicated genotypes 48 h after activation with LPS and IL-4. The DNA bands of 447 bp for the intact spliced
(Xbp1-s) transcript RT-PCR product, and the unspliced (Xbp1-u) transcript digestion products of 290 and 183 bp, are indicated. Results for three mice per
genotype are shown. (D) Representative WB analysis of splenocytes of the indicated genotypes 72 h after activation with LPS and IL-4. Resting B cells from a
WT control mouse (Ctrl) were analyzed in parallel to show the expected undetectable levels of Xbp1-s before activation. 1 and 2 indicate two different mice per
genotype. Numbers underneath the blot indicate relative quantification of Xbp1-s signal. (E) Top: Representative ELISpot analysis of IgM+ ASCs in BM and SPL
of unimmunized mice. Bottom: Summary graphs showing number of IgM+ ASCs and mean surface of IgM+ spots for three mice per genotype and age group. N,
number. No difference among groups was significant for graphs in A, B, and E (Mann–Whitney U test).
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Activation of na¨ıve B cells with specific combinations of
stimuli in vitro induces differentiation into plasmablasts. Plas-
mablasts are proliferating antibody-secreting cells (ASCs) whose
differentiation is driven by the same transcriptional program
responsible for plasma cell development (Nutt et al., 2015).
Therefore, we tested the formation of plasmablasts (B220+CD138+)
in vitro under the same stimulation conditions used for our pre-
vious analyses. We observed no significant difference in the
percentage of plasmablasts between controls and Pdap1F/FCd19Cre/+
cultures (Fig. 7 B). Accordingly, we did not detect any apparent
change in the activation of the plasmablast and plasma cell gene
signature between the two genotypes in the RNA-seq analysis
(Table S1). We concluded that Atf4 up-regulation in activated
Pdap1F/FCd19Cre/+ B cells does not inhibit the generation of plas-
mablasts and plasma cells, and that Pdap1 is not required for the
B cell developmental program controlling plasmablast and plasma
cell formation and identity.
The ER expansion and increase in protein processing and
folding capabilities of plasma cells are regulated by the tran-
scription factor Xbp1-s (spliced Xbp1; Shaffer et al., 2004). Xbp1
deficiency in B cells does not interfere with the development of
plasma cells but impairs immunoglobulin secretion because of
defective expansion of the secretory pathway (Hu et al., 2009;
Todd et al., 2009; Taubenheim et al., 2012; Shaffer et al., 2004).
Xbp1-s is expressed as a result of an unconventional splicing
event mediated by Ire1 that removes a 26-nt segment from Xbp1
mRNA (unspliced Xbp1 transcript, Xbp1-u), thus changing the
transcript reading frame in the resulting spliced Xbp1 transcript
(Xbp1-s; Fig. 7 C; Yoshida et al., 2001). Xbp1-s translocates into
the nucleus and activates the transcription of genes responsible
for the expansion of the secretory pathway (Shaffer et al., 2004;
Tellier et al., 2016). We found no difference in Xbp1 mRNA
splicing and Xbp1-s expression levels between control and
Pdap1F/FCd19Cre/+ splenocyte cultures (Fig. 7, C and D). These
results suggest that the transcriptional program controlling ER
network expansion in plasma cells is not affected by Pdap1 de-
letion. Finally, ELISpot analysis did not detect any significant
difference in the number or spot size of ASCs between the two
groups (Fig. 7 E), thus indicating that antibody production is not
affected by Pdap1 deficiency. We concluded that Pdap1 is dis-
pensable for the differentiation programs that establish plasma
cell identity and function under steady-state conditions.
Pdap1 is required for efficient SHM of Ig loci
Aicda is a haploinsufficient gene, and Aicda+/− mice exhibit de-
fects in both antibody diversification reactions initiated by AID,
CSR, and SHM (McBride et al., 2008; Serna´ndez et al., 2008;
Takizawa et al., 2008). Given the reduced levels of AID ex-
pressed by Pdap1F/FCd19Cre/+ B cells following activation, we
considered the possibility that Pdap1 depletion might also affect
SHM. To test this hypothesis, we sequenced the intronic regions
downstream of the JH4 and JK5 elements in GC B cells sorted
from Peyer’s patches of aged Pdap1F/FCd19Cre/+ mice (Jolly et al.,
1997). Because of their chronic exposure to microbial antigens,
GC B cells in Peyer’s patches accumulate a high number of
mutations over time (Gonza´lez-Ferna´ndez et al., 1994). Accord-
ingly, we found that GC B cells from control mice displayed a
high mutation frequency at both JH4 and JK5 intronic regions
(Fig. 8, A–D). The vast majority of sequences contained muta-
tions (86%, 79 of 92 for JH4, and 83%, 104 of 125 for JK5), and a
considerable portion of B cells were heavily mutated (Fig. 8, E
and F). In contrast, Pdap1F/FCd19Cre/+ GC B cells exhibited a sig-
nificantly lower mutation frequency at both JH4 and JK5 in-
trons (Fig. 8, A–D). The distribution of mutations per
sequence was skewed toward an increase in the proportion of
sequences bearing zero or fewer than five mutations (50%, 54
of 107 for JH4, and 65%, 83 of 127 for JK5), whereas the number
of highly mutated clones was concomitantly reduced (Fig. 8, E
and F). In agreement with a role of Pdap1 in promoting AID
expression rather than the processing of AID-induced lesions,
the profile of mutations was not affected by Pdap1 deletion
(Fig. 8, G and H).
Altogether, these findings indicate that ablation of Pdap1
impairs the efficiency of SHM of heavy and light chain Ig loci.
Therefore, Pdap1 is required to support both antibody diversi-
fication reactions occurring in mature B cells, namely CSR
and SHM.
Discussion
In this study, we report the identification of a novel factor required
for mature B cell homeostasis and function. Pdap1-deficient B cells
develop normally but display reduced cell viability at the mature
stage both in vitro and in vivo. Furthermore, they fail to efficiently
induce AID expression and cannot support physiological levels of
CSR and SHM.
Pdap1 deficiency in mature B cells phenocopies key aspects of
the cellular response to chronic stress. Stress-induced eIF2α
phosphorylation drives the inhibition of global protein synthesis,
while allowing the preferential translation of stress-responsive
genes like Atf4 (Harding et al., 2000; Hinnebusch, 2000;
Scheuner et al., 2001; Lu et al., 2004). The transcriptional
program induced by Atf4 comprises cytoprotective genes as
well as the up-regulation of biosynthetic pathways to repro-
gram cellular metabolism and aid homeostasis recovery. This
anabolic program encompasses metabolic pathways of amino
acid biosynthesis and the expression of amino acid transporter
and aminoacyl-tRNA synthetase genes, and supports recovery
of translation under conditions of acute stress (Harding et al.,
2003; Rendleman et al., 2018; Quirós et al., 2017; Krokowski
et al., 2013; Han et al., 2013). However, during chronic stress,
Atf4-dependent increase in protein synthesis leads to proteo-
toxicity, oxidative stress, and cell death (Han et al., 2013;
Krokowski et al., 2013). Pdap1-deficient B cells express Atf4 and
exhibit the same transcriptional signature of Atf4-mediated
translational recovery (Fig. 5, Fig. S5, and Table S1). Fur-
thermore, the expression of this anabolic program correlates
with increased apoptosis of Pdap1F/FCd19Cre/+ B cells. Therefore,
our data are consistent with a model in which ablation of Pdap1
in activated B cells leads to cell death via induction of an Atf4-
dependent chronic stress response. In addition, resting B cells
from Pdap1-deficient mice displayed phosphorylation of Perk
and its downstream target eIF2α as well as Atf4 expression,
thus indicating constitutive activation of the Perk-mediated ISR
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pathway. This result is in agreement with the reduced number
of resting B cells isolated from spleens of Pdap1F/FCd19Cre/+ (Fig.
S1 E) and indicates that Pdap1 deficiency is also detrimental in
naı¨ve B cells. Therefore, Pdap1 is required to protect B
lymphocytes from stress-induced cell death under both resting
and activated conditions.
Interestingly, while Atf4 expression increased steadily over
time after activation in Pdap1-deficient B cells, phosphorylation
Figure 8. Pdap1 is required for efficient SHM of Ig loci. (A and B) Graphs summarizing number of mutations in 39 JH4 (A) and 39 Jk5 (B) regions cloned from
sorted Peyer’s patches B cells of aged, unimmunized mice (five mice per genotype). Each symbol in the graphs indicates a single sequence, and the total number
of sequences analyzed for each group is indicated below. Mutations were quantified for 510-bp downstream JH4 gene segment (A) and 536-bp downstream JK5
gene segment (B). NGC, non–GC. (C and D) Summary tables listing number of analyzed sequences and total length, number of mutations, and mutation
frequency at JH4 (C) and JK5 (D) introns from A and B. (E and F) Graphs showing the percentage of sequences from A and B bearing the indicatedmutations in 39
JH4 (E) and 39 Jk5 (F). (G and H) Profiles of nucleotide substitutions at 39 JH4 (G) and 39 Jk5 (H) regions. Significance in A and B was calculated with the
Mann–Whitney U test, and the median is indicated. **, P ≤ 0.01; ****, P ≤ 0.0001.
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of Perk and eIF2αwas no longer detectable. This observation has
two important implications. First, the up-regulation of Atf4
expression in Pdap1-ablated cells is uncoupled from Perk-eIF2α
phosphorylation following activation. This result is in agree-
ment with the identification of a phospho-eIF2α–independent
regulation of Atf4 expression observed during conditions of
prolonged cellular stress (Guan et al., 2014). This regulation is
likely under the control of mTORC1, which is activated in B cells
after stimulation (Powell et al., 2012; Limon and Fruman, 2012;
Iwata et al., 2017), and has been shown to promote Atf4 trans-
lation in a phospho-eIF2α–independent manner in other cellular
contexts (Park et al., 2017; Ben-Sahra et al., 2016). Second, the
dephosphorylation of Perk and eIF2α occurs at early time points
after activation. This observation implies the existence of an
active mechanism operating immediately upon B cell activation
that physiologically inhibits the Perk-eIF2α signaling cascade. In
line with this point, although mature B cells retain the potential
to activate all three arms of the UPR in response to pharmaco-
logical triggers of the pathway, the Perk branch is suppressed
during normal differentiation of activated B cells into plasma
cells (Ma et al., 2010; Gass et al., 2008; Zhang et al., 2005).
Moreover, nonphysiological Perk-eIF2α-Atf4 signaling after
B cell activation even blocks the formation of plasma cells (Zhu
et al., 2019). In Pdap1F/FCd19Cre/+ splenocytes, the Perk-eIF2α-
Atf4 pathway is already active under resting conditions, and the
increased loss of mitochondrial membrane potential and apo-
ptosis were observed at early, but not late, stages after activa-
tion. The earlier kinetics of Atf4 induction in our experimental
conditions would explain why Pdap1 deficiency leads to cell
death of na¨ıve and early activated B cells but does not affect the
plasma cell compartment. It is important to note that the
analysis of plasma cell differentiation and function was per-
formed under steady-state conditions; therefore, we cannot
completely exclude the possibility that Pdap1 deficiency might
affect plasma cell differentiation following immunization.
The activation of the Atf4-dependent stress response in
Pdap1F/FCd19Cre/+ B cells was accompanied by down-regulation
of key factors driving antibody diversification, including AID
(Muramatsu et al., 2000; Revy et al., 2000) and the tran-
scription factor Batf, which has been shown to directly control
AID expression and other aspects of the CSR program (Ise
et al., 2011). Defective induction of Aicda expression in acti-
vated Pdap1-deficient B cells was common to all stimulation
conditions (Figs. 3 A and 5 C) and likely represents the dom-
inant cause for the reduced CSR and SHM efficiency. Aicda is
an haploinsufficient gene, and the efficiency of CSR is directly
proportional to AID levels. Mice heterozygous for a null Aicda
allele display defects in both CSR and SHM (McBride et al.,
2008; Serna´ndez et al., 2008; Takizawa et al., 2008). Analo-
gously, Pdap1 deficiency reduced Aicda expression to ap-
proximately half of WT levels in activated B cells and is
associated with a similar reduction in the efficiency of both
antibody diversification reactions. Furthermore, overexpression
of AID in LPS-BAFF-TGFβ–stimulated splenocytes, which
did not exhibit any additional defect in GLT, rescued the
IgG2b CSR defect of Pdap1F/FCd19Cre/+ B cells to a consider-
able extent.
Pdap1 might control activation of the ISR and the antibody
diversification program via independent mechanisms.We found
that Pdap1 is localized primarily in the cytoplasm in different
cell types. Considering this observation and that Pdap1 was re-
cently described as a RNA-binding protein (Castello et al., 2012,
2016; Iadevaia et al., 2020; Trendel et al., 2019; Baltz et al., 2012),
it is tempting to hypothesize that it might play a role in mRNA
turnover. In regard to AID, however, we showed that Pdap1
promotes its efficient expression but is dispensable for Aicda
transcript stability. Therefore, a potential involvement of Pdap1
in the regulation of AID levels via control of mRNA turnover
would occur indirectly, e.g., via modulation of the expression of
intermediate factors. Although we cannot exclude the possibility
that Pdap1 might regulate the expression of AID independently
from its protective role against chronic ISR activation, we favor
the hypothesis that the two processes are tightly linked. It is
intriguing to speculate that the sustained induction of the ISR in
Pdap1F/FCd19Cre/+ B cells might actively interfere with the CSR
and SHM programs. In this respect, limiting AID expression
under conditions of cellular stress might represent a mecha-
nism to alleviate the additional burden imposed by AID-induced
genotoxic stress on activated B cells. Analysis of humoral
responses upon genetic deletion of ISR components on a Pdap1-
deficient background would provide the basis for a new
exciting line of investigation into the relationship between
response to cellular stresses and antibody gene diversification in
mature B cells.
Materials and methods
Mouse strains
Cd19Cre (Cd19tm1(cre)Cgn; Rickert et al., 1997) and Aicda−/−
(Aicdatm1Hon/tm1Hon; Muramatsu et al., 2000) mice were previ-
ously described and were maintained on a C57BL/6 background.
The conditional Pdap1F allele bears LoxP sites flanking Exon
2 (ENSMUST00000031627.8) and was generated by CRISPR-
Cas9–mediated knock-in microinjection of single-cell embryos
on a C57BL/6N strain background (Max Delbrück Center [MDC]
Transgenics platform). Germline transmission was confirmed,
and positive pups were bred with Cd19Cre mice to generate
Pdap1F/FCd19Cre/+ mice. Mice were maintained in a specific
pathogen-free barrier facility under standardized conditions
(20°C ± 2°C; 55 ± 15% humidity) on a 12-h light/dark cycle. 7–27-
wk-old mice of both genders were used in age-matched groups
for the experiments. Controls included littermates and mice
from inbred strains. All experiments were performed in com-
pliance with European Union directive 2010/63/EU and in
agreement with Landesamt für Gesundheit und Soziales direc-
tives (Berlin, Germany). Primers used for genotyping the Pdap1F
allele are listed in Table S2.
Primary cell cultures
B lymphocytes were isolated from mouse spleens using anti-
CD43 MicroBeads (Miltenyi Biotec) and grown in RPMI 1640
(Life Technologies) supplemented with 10% FBS, 10 mM Hepes
(Life Technologies), 1 mM sodium pyruvate (Life Technologies),
1× Antibiotic Antimycotic (Life Technologies), 2 mM L-glutamine
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(Life Technologies), and 1× 2-mercaptoethanol (Life Technolo-
gies) at 37°C and 5% CO2.
Cell lines
The cell lines used for this study were CH12 (CH12F3, mouse;
Nakamura et al., 1996); WT (R1 and R2) and Pdap1-deficient (P1,
P2, and P3) CH12 clonal derivatives (mouse; this paper); BOSC23
(human; Pear et al., 1993); and immortalized mouse embryonic
fibroblasts (iMEFs; Bothmer et al., 2011). CH12 cells were grown
in RPMI 1640 supplemented with 10% FBS, 10 mM Hepes, 1 mM
sodium pyruvate, 1× Antibiotic Antimycotic, 2 mM L-glutamine,
and 1× 2-mercaptoethanol at 37°C and 5% CO2. BOSC23 cells and
iMEFs were cultured in DMEM (Life Technologies) supple-
mented with 10% FBS, 2 mM L-glutamine, and penicillin-
streptomycin (Life Technologies) at 37°C and 5% CO2.
CSR assay
CH12 cells were stimulated to undergo CSR to IgA by treat-
ment with 1–5 µg/ml αCD40 (BioLegend), 5 ng/ml TGFβ (R&D
Systems), and 5 ng/ml mouse recombinant IL-4 for 48 h. B
lymphocytes were stimulated to undergo class switching with
5 µg/ml LPS (Sigma-Aldrich) and 5 ng/ml mouse recombinant
IL-4 (Sigma-Aldrich) for CSR to IgG1; 5 µg/ml LPS only for
CSR to IgG3; 5 µg/ml LPS, 10 ng/ml BAFF (PeproTech), and
2 ng/ml TGFβ for CSR to IgG2b; or 5 µg/ml LPS, 10 ng/ml
BAFF, 2 ng/ml TGFβ, and 1.5 ng/ml recombinant murine IL-5
(PeproTech) for CSR to IgA. For class switching analysis, cell
suspensions were stained with fluorochrome-conjugated anti-IgG1,
anti-IgG3 (BD Biosciences), anti-IgG2b (BioLegend), or anti-IgA
(Southern Biotech).
Retroviral infection
The pMX-AID-ER-IRES-GFP retroviral vector was a kind gift
from Qiao Wang (The Rockefeller University, New York, NY).
Splenocyte infections were performed as follows. The HEK293T
derivative cell line BOSC23 was transfected with pCL-Eco and
pMX-IRES-GFP or pMX-AID-ER-IRES-GFP retroviral vectors
using FuGENE HD Transfection Reagent (Promega) to generate
viral particle–containing supernatants. B cells were activated
with 5 µg/ml LPS and 5 ng/ml IL-4 (IgG1) or 5 µg/ml LPS, 10 ng/
ml BAFF, and 2 ng/ml TGFβ (IgG2b) and transduced twice with
the viral supernatant, 1 and 2 d after isolation. 4-HT was added
72 h after activation at a final concentration of 0.05 µM, and CSR
was assessed 24 h later on the GFP+-gated populations. The
pMX-Pdap1-3xFlag construct was generated by cloning the
cDNA for human Pdap1 into pMX retroviral vector with a
C-terminal 3xFlag tag. Primers used to clone the pMX-Pdap1-
3xFlag construct are listed in Table S2. iMEFs infections were
performed as indicated above for splenocytes, except that cells
were transduced with pCL-Eco and pMX-EV/pMX-Pdap1-
3xFlag-viral supernatants four times over 2 d. 48 h after the first
transduction, iMEFs were selected using 1.5 µg/ml puromycin
(Sigma-Aldrich).
B cell development and differentiation analyses
For analysis of B cell development and differentiation, spleen
and bone marrow cell suspensions were incubated with ACK
lysis buffer (Thermo Fisher Scientific) for erythrocyte depletion.
Subsequently, cells were blocked with TruStain fcX (BioLegend)
for 10 min at 4°C and labeled with fluorochrome-conjugated
antibodies to determine the surface expression of CD43, IgM,
CD21/CD35, and IgD (BD Biosciences), and CD23, CD3, and CD19
(BioLegend) in PBS supplemented with 3% FBS (PBS/FBS) for
20min at 4°C. Cells were then washed, resuspended in PBS/FBS,
and analyzed.
For analysis of plasma cell differentiation in vitro, splenic
B cells were isolated by immunomagnetic depletion of CD43+
cells and cultured at a density of 106 cells/ml in the presence
of either 20 µg/ml LPS (Sigma-Aldrich; L2880-10MG) and
25 ng/ml IL-4, or 20 µg/ml LPS, 10 ng/ml BAFF, and 2 ng/ml
TGFβ. To determine the percentage of plasmablasts, cells were
harvested after 96 h, blocked with TruStain fcX for 10 min at
4°C, and stained for surface expression of B220 (BioLegend;
103245) and CD138 (BioLegend; 142506) in MACS buffer (PBS
supplemented with 0.5% BSA and 2 mM EDTA) for 20 min at
4°C. Cells were then resuspended in FACS buffer (PBS sup-
plemented with 3% FCS and 1 mM EDTA) containing 1 µg/ml
propidium iodide and analyzed.
For analysis of the plasma cell compartment in vivo, 9-, 14-,
and 25-wk-old mice were sacrificed to isolate the spleen and
hind legs. Total splenocytes and bonemarrow cells were isolated
by smashing the respective organs, and erythrocytes were de-
pleted by incubation with Gey’s ABC solution for 3 min on ice.
For surface staining, 5 × 106 cells were first blocked with
TruStain fcX for 10 min at 4°C and then stained for the following
markers for 20 min at 4°C in MACS buffer: CD138, TACI (BD
PharMingen; 558410), CD93 (BioLegend; 136506), CD19 (Bio-
Legend), and B220. Cells were resuspended in FACS buffer
containing 1 µg/ml propidium iodide and analyzed.
For ELISpot analysis, MultiScreenHTS-IP plates (Merck) were
activated with 35% ethanol in PBS for 1 min, washed three times
with PBS, and finally coated with 1 µg/ml anti-Igκ (Southern
Biotech) and anti-Igλ (Southern Biotech) in PBS at 4°C over-
night. The following day, 2 × 105 total splenocytes or BM cells (as
well as serial fivefold dilutions) were cultured overnight in
RPMI 1640 supplemented with 10% FCS (Sigma-Aldrich) and
penicillin-streptomycin. The next day, plates were washed
thoroughly six times with PBS containing 0.1% Tween20 and
incubated with 1 µg/ml biotinylated antibodies against IgM
(Southern Biotech) for 2 h at 37°C. Plates were washed three
times under running distilled water and incubated with 0.3
U/ml streptavidin-AP (Roche) for 30 min at room temperature.
For detection of spots, plates were washed three times under
running distilled water, equilibrated in AP buffer (100mMTris-
HCl, pH 9.0, 150 mM NaCl, and 1 mM MgCl2), and developed
using NBT/BCIP substrate mix (Promega) diluted in AP buffer.
Spots were scanned and counted using the ImmunoSpot Series 6
Alfa Analyzer and ImmunoCapture Image Acquisition as well as
ImmunoSpot Analysis software (C.T.L.) with the following pa-
rameters: sensitivity 176, spot separation 1.00, diffuseness
largest, background balance 40, minimum spot size 0.0015mm2,
and maximum spot size 0.6976 mm2.
For assessment of GC B cells and CSR in vivo, cell suspensions
derived from Peyer’s patches were blockedwith TruStain fcX for
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10min at 4°C. Subsequently, cells were stainedwith fluorochrome-
conjugated anti-CD19, anti-B220/CD45R, anti-CD38 (BioLegend),
anti-Fas/CD95, and anti-IgA (BD Biosciences) for 20 min at 4°C in
PBS/FBS. Cells were washed, resuspended in PBS/FBS, and ana-
lyzed. All samples were acquired on a LSRFortessa cell analyzer
(BD Biosciences).
Immunofluorescence
Resting B cells and CH12 were fixed with 4% paraformaldehyde
(Sigma-Aldrich) and permeabilized with PBST (0.1% Tween 20
in PBS 1×) containing 0.2% IGEPAL CA-630 (Sigma-Aldrich).
Cells were stained with antibodies against Pdap1 (Sigma-
Aldrich), rat anti-mouse IgM-PE (BD Biosciences), and goat
anti-rabbit Alexa Fluor 488 (Abcam). Cells were incubated with
permeable nuclear dye (Hoechst dye 33258, Thermo Fisher
Scientific) and transferred onto slides for imaging.
iMEFs infected with either empty pMX vector (EV) or pMX-
Pdap1-3xFlag construct were grown on coverslips overnight.
Upon fixation with 4% paraformaldehyde and permeabilization
with 0.5% Triton X-100, cells were stained with mouse anti-Flag
M2 (Sigma-Aldrich), goat anti-mouse Alexa Fluor 546 (In-
vitrogen), and Hoechst dye 33258. Images were acquired using
inverted LSM700 AxioObserver laser scanning confocal micro-
scope (Zeiss), with Plan-Apochromat 63×/1.40 Oil Ph3 objective
for primary B cells and CH12, and EC Plan-Neofluar 40×/1.30 Oil
Ph3 objective for iMEFs.
Cell proliferation and apoptosis analysis
For cell proliferation analysis by cell tracking dye dilution, pri-
mary B cells were pulsed with 5 µM CellTrace Violet (Thermo
Fisher Scientific) for 10 min at 37°C. Apoptosis analysis was
performed by using CaspGLOW Fluorescein Active Caspase
Staining Kit (BioVision) according to the manufacturer’s in-
structions. Samples were acquired on a LSRFortessa cell ana-
lyzer (BD Biosciences). Mitochondrial mass and membrane
potential were measured via staining with MitoTracker Green
and DeepRed (Thermo Fisher Scientific), respectively, according
to the manufacturer’s instructions. Samples were acquired on a
LSRFortessa cell analyzer (BD Biosciences).
CRISPR-Cas9 gene targeting
For the loss-of-CSR assay in bulk CH12 cultures, three gRNAs
against Pdap1 gene were cloned into the U6 cassette of a variant
of the original pX330 plasmid (pX330-U6-Chimeric_BB-CBh-
hSpCas9, Addgene; 42230)modified to express Cas9WT-T2A-GFP
(kind gift from Van Trung Chu, MDC; gPdap1-1/3), and three
gRNA pairs were cloned into tandem U6 cassettes in a mutated
version of pX330 expressing Cas9D10A (Nickase-a/c). CH12 cells
were transfected with the Cas9-gRNAs expressing constructs
(either individually or in a pooled format) via electroporation
with Neon Transfection System (Thermo Fisher Scientific),
sorted for GFP-positive cells after 40 h, and left to recover for
72 h before activation for CSR analysis. For the generation of
Pdap1-deficient CH12 clonal derivatives, the Nickases-a/c con-
structs were individually electroporated into CH12. Single GFP-
positive cells were sorted in 96-well plates after 40 h, and clones
were allowed to grow for 12 d before CSR analysis in 96-well
format and expansion of selected clones. Controls for gRNA-
nucleofected CH12 were cells nucleofected with either empty
vector or gRNAs against random sequences not present in the
mouse genome (single random gRNA-Cas9WT as controls for
gPdap1-1/3, and random gRNAs pairs-Cas9D10A as controls for
Nickase-a/c). Selected clones R1/R2 and P1/3 were validated at
the level of genomic scar and protein expression. The sequences
of the gRNAs used in these studies (this paper; Delgado-Benito
et al., 2018) are listed in Table S2.
WB analysis
WB analysis of protein levels was performed on whole-cell ly-
sates prepared by lysis in radioimmunoprecipitation assay
buffer (Sigma-Aldrich) supplemented with Complete EDTA free
proteinase inhibitors (Roche). Pierce Phosphatase InhibitorMini
Tablets (Thermo Fisher Scientific) were added to the lysis buffer
for the analysis of phosphorylated Perk and eIF2α. The anti-
bodies used for WB analysis are anti-Pdap1 (Sigma-Aldrich),
anti-tubulin (Abcam), anti-β-actin (Sigma), anti-AID (mAID-2;
Thermo Fisher Scientific), anti-phospho-Perk (pThr980; Thermo
Fisher Scientific), anti-Perk (Cell Signaling Technology), anti-
phospho-eIF2α (pSer51; Cell Signaling Technology), anti-eIF2α
(Santa Cruz), anti-Atf4 (Cell Signaling Technology), and anti-
Xbp1-s (Cell Signaling Technology). WB signals were quantified
using ImageJ (National Institutes of Health), and normalization
was performed against loading controls.
qPCR
mRNA levels for AID and postspliced germline transcripts were
measured as follows. Total RNA was extracted from splenocyte
cultures 48 h after activation using TRIzol (Invitrogen) accord-
ing to manufacturer’s instructions and retro-transcribed with
SuperScript VILO cDNA Synthesis Kit (Invitrogen). Genomic
DNA was removed by RapidOut DNA Removal Kit (Thermo
Fisher Scientific). Transcripts were amplified using StepOne-
Plus Real-Time PCR System (Applied Biosystems) with Luna
Universal qPCR Mastermix (NEB). For analysis of Aicda mRNA
decay, Actinomycin D was added to the culture medium 48 h
after activation at a final concentration of 10 µg/ml for 0.5, 1, 1.5,
2, 3, and 4 h. qPCR analyses were normalized to Ubc or Gapdh
(Aicda mRNA and GLTs) or Gapdh (AicdamRNA decay). Primers
used for qPCR (this paper; Xu et al., 2015; Muramatsu et al.,
2000; Albershardt et al., 2012) are listed in Table S2.
For electrophoretic analysis of Xbp1 splicing, Xbp1 transcripts
were amplified using the primers listed in Table S2 (Madaro
et al., 2013) and either mock-digested or digested with PstI en-
zyme (NEB) for 30 min at 37°C. The intact spliced (Xbp1-s)
transcript RT-PCR product and the unspliced (Xbp1-u) transcript
digestion products were visualized on 2% agarose gel.
RNA-seq
RNA-seq was performed on three mice per genotype. Spleno-
cytes were cultured in LPS and IL-4 (IgG1) or LPS, BAFF, and
TGFβ (IgG2b) for 48 h. Cells were collected by centrifugation,
and RNA was extracted with TRIzol (Invitrogen) according to
manufacturer’s instructions. Ribosomal RNA was depleted using
Ribo-Zero Gold rRNA Removal Kit (Illumina). Libraries were
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prepared with TruSeq Stranded Total RNA Library Prep Kit Gold
(Illumina) and run in one lane of a flow cell of HiSeq 4000
(Illumina).
The RNA-seq data were analyzed using the pigx-rnaseq
pipeline (Wurmus et al., 2018). STAR (Dobin et al., 2013) map-
ped the reads to the GRCm38 assembly for mouse by Ensembl,
and HTSeq (Anders et al., 2015) was used to count the transcript
abundance. Differential expression analysis was done using the
DESeq2 (Love et al., 2014) package for R, which uses the Wald
test for significance.
For splicing analysis of Aicda and Pdap1 genes, we used the
edgeR (Robinson et al., 2010) package for R to determine dif-
ferentially expressed exons. The annotation was provided by a
filtered version of the GRCm38 gene annotation, which con-
tained unique, Havana-annotated exons.
SHM analysis
Single-cell suspensions from Peyer’s patches of 24–27-wk-old
mice were first incubated with TruStain fcX, and then labeled
with antibodies conjugated with B220-FITC (BioLegend), CD19-
APC/Pacific Blue (BioLegend), CD38-Alexa Fluor 700 (Thermo
Fisher Scientific), and CD95/Fas-PE (BD Biosciences). Non-GC
(CD38+ Fas−) and GC B cells (CD38− Fas+) were sorted on an
Aria BD sorter. Genomic DNA was extracted, and the 59 portions
of JH4 (Igh) and JK5 (Igk) introns were amplified by PCR using
Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scien-
tific). The 800-bp JH4 and 700-bp JK5 PCR products were gel
extracted, cloned into a pCR2.1 vector using the TOPO TA
Cloning Kit (Invitrogen), and sequenced. Mutations were
quantified over 510-bp downstream JH4 and 536-bp downstream
JK5 gene segments. Primers used for SHM analysis (Rouaud
et al., 2013; Sander et al., 2015) are listed in Table S2.
Seahorse assay
Oxygen consumption rate and extracellular acidification rate
were measured with the Seahorse XF96metabolite analyzer using
the Seahorse XF Cell Mito Stress Test kit (Agilent). Primary B cells
were isolated, counted, and plated at the indicated cell densities
directly on Seahorse cell culture plates coated with poly-L-lysine
(Sigma-Aldrich). Before measurement, cells were incubated for a
maximum of 1 h in Seahorse XF DMEM medium pH 7.4 (Agilent)
supplemented with 10 mM glucose (Agilent), 1 mM sodium py-
ruvate (Agilent), and 2 mM L-glutamine (Agilent).
Statistical analysis
The statistical significance of differences between groups/data-
sets was determined by the Mann–Whitney U test for all data
presented in this study, with the following exceptions. For the
RNA-seq analysis, theWald test of the DESeq2 package for R was
used, and we considered genes with an FDR < 0.05 to be sig-
nificantly differentially expressed. Statistical details of experi-
ments can be found in the figure legends.
Data availability
The deep-sequencing data reported in this paper (RNA-seq) has
been deposited in the GEO repository under accession no.
GSE141876.
Online supplemental material
Fig. S1 shows that Pdap1 is dispensable for B cell development.
Fig. S2 shows that Pdap1 is dispensable for B cell proliferation.
Fig. S3 shows that Aicda mRNA levels are reduced in Pdap1-
deficient CH12 cell lines. Fig. S4 shows that Pdap1 is localized
primarily in the cytoplasm in B cells andMEFs. Fig. S5 shows the
stress response signature of Pdap1-deficient B cells. Table S1
contains the pairwise comparison of differentially regulated
genes in control versus Pdap1F/FCd19Cre/+ splenocytes. Table S2
lists the oligonucleotides used in this study.
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Figure S1. Pdap1 is largely dispensable for B cell development. (A) Schematic representation of Pdap1 locus and genotyping strategy. WT, WT Pdap1 allele;
Flox, conditional Pdap1 allele; Δ, null Pdap1 allele. (B) Electrophoretic analysis of Pdap1 allele status in resting splenic B cells isolated from mice of the indicated
genotype. (C) Representative flow cytometry analysis of lymphoid tissues from control and Pdap1F/FCd19Cre/+ mice. (D) Summary graphs for four mice per
genotype. (E) Number of resting B cells isolated from spleens of the indicated genotype. Each dot represents a different mouse. Significance in D and E was
calculated with the Mann–Whitney U test, and error bars represent SD. No difference among groups was significant for graphs in D. ****, P ≤ 0.0001.
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Figure S2. Pdap1 is dispensable for B cell proliferation. (A–D) Proliferation analysis by CellTrace Violet dilution of primary cultures of Cd19Cre/+ and
Pdap1F/FCd19Cre/+ B lymphocytes stimulated with LPS-IL-4 (A), LPS only (B), LPS-BAFF-TGFβ (C), or LPS-BAFF-TGFβ-IL-5 (D). Data are representative of at least
two mice per genotype. (E) Graph showing percentage of IgG1+ cells per cell division in primary cultures of Cd19Cre/+ and Pdap1F/FCd19Cre/+ splenocytes
stimulated with LPS and IL-4 for 72 h. Graph summarizes at least three mice per genotype, and error bars represent SD. Representative cell division plots as
measured by CellTrace Violet dilution are shown on top. (F) Representative overlay of CellTrace Violet proliferation tracks of LPS-IL-4 and LPS-BAFF-TGFβ
cultures 48 h after activation.
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Figure S3. AicdamRNA levels are reduced in Pdap1-deficient CH12 cell lines. (A) qPCR analysis for AicdamRNA in activated CH12 cell lines of the indicated
genotypes. Graph summarizes four independent experiments. Parental WT CH12 cells within each experiment were assigned an arbitrary value of 1. (B and C)
qPCR analysis for Igμ (B) and Igα (C) GLT levels in activated CH12 cell lines of the indicated genotypes. The schematic representations on top of each graph
indicate the location of primers used to analyze postspliced germline transcripts. Graphs summarize four independent experiments. Parental WT CH12 cells
within each experiment were assigned an arbitrary value of 1. Significance in A was calculated with the Mann–Whitney U test. Error bars represent SD. *, P ≤
0.05.
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Figure S4. Pdap1 is localized primarily in the cytoplasm. (A–C) Immunofluorescence staining of Pdap1 in WT primary B cells (resting splenocytes; A), CH12
(unactivated and 48 h after activation; B), and iMEFs (C). Staining is against endogenous Pdap1 in A and B and Pdap1-3xFlag in C. EV, empty vector. Scale bars in
A–C indicate 5, 2, and 10 µm, respectively.
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Figure S5. Stress response signature of Pdap1-deficient B cells. (A) Coverage of stress response genes in B cells of the indicated genotypes 48 h after
activation with LPS and IL-4 (L-I4) or LPS, BAFF, and TGFβ (L-B-Tβ), as measured by RNA-seq analysis. 10 selected genes are shown. (B) WB analysis as in
Fig. 5 D for an independent mouse pair (control and Pdap1F/FCd19Cre/+). Splenocytes were isolated (resting B cells) and activated for 24–96 h with LPS and IL-4.
Quantification values of WB signals are indicated underneath the corresponding blots. (C) Graphs showing oxygen consumption rate (OCR) and extracellular
acidification rate (ECAR) analysis of resting primary B cell cultures. Filled and empty symbols indicate 106 or 0.5 × 106 cells/well seeding densities, respectively.
Each data point represents the mean of three independent measurements, with error bars indicating SD. Labeled arrows denote injections of the indicated
agents.
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Table S1 shows a pairwise comparison of differentially regulated genes in control versus Pdap1F/FCd19CRE/+ splenocytes. Table S2
lists the oligonucleotides used in this study.
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